Literature DB >> 9552714

Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, Zimbabwe.

P R Mason1, L Gwanzura, A S Latif, E Marowa, S Ray, D A Katzenstein.   

Abstract

The objective is to compare antibiotic resistance amongst gonococci isolated from different patient groups in Harare, Zimbabwe. Antimicrobial susceptibilities of Neisseria. gonorrhoeae were determined by disc sensitivity tests. The MICs for penicillin, kanamycin, ceftriaxone, norfloxacin and ciprofloxacin were determined using E-test strips. There were 147 isolates from symptomatic men, 47 isolates from symptomatic women, 29 isolates from asymptomatic women and 41 isolates from female commercial sex workers. A total of 119 (45%) isolates were PPNG and 23 (16%) non-PPNG isolates had a penicillin MIC > 0.64 mg/l. Over 90% of isolates were resistant to TMP/SMX and 16% were resistant to tetracycline. Resistance was uncommon against kanamycin (6%), erythromycin (2%) or ceftriaxone ( < 1%). For kanamycin, the MIC90 was 32 mg/l, for ceftriaxone the MIC90 was < 0.032 mg/l for non-PPNG and < 0.064 mg/l for PPNG. For norfloxacin and ciprofloxacin the MIC90 was < 0.064 mg/l for both PPNG and non-PPNG. Isolates from the commercial sex workers showed a significantly increased prevalence of PPNG, of penicillin-tolerant non-PPNG and of tetracycline resistance. Four of the 41 isolates from sex workers showed multiple resistance (to penicillin, TMP/SMX, tetracycline and kanamycin) compared to 1/223 isolates from other groups (OR = 24.0). Antimicrobial resistance is common amongst gonococci in Harare, especially with isolates from commercial sex workers. In order for STD treatment to be implemented as an effective strategy in HIV control, continued monitoring of resistance patterns is essential.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9552714     DOI: 10.1016/s0924-8579(97)00052-6

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998.

Authors:  M Tanaka; H Nakayama; M Haraoka; T Saika
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016.

Authors:  Alexey Kubanov; Viktoria Solomka; Xenia Plakhova; Aleksandr Chestkov; Natalya Petrova; Boris Shaskolskiy; Ekaterina Dementieva; Arvo Leinsoo; Dmitry Gryadunov; Dmitry Deryabin
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

3.  A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle?

Authors:  Andrew Nyerere Kimang'a
Journal:  Ethiop J Health Sci       Date:  2012-07

4.  Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.

Authors:  Thomas Regnath; Thomas Mertes; Ralf Ignatius
Journal:  Euro Surveill       Date:  2016-09-08

5.  Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse.

Authors:  Bhawna Malik; Samit Bhattacharyya
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

6.  Epidemiology of Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and herpes simplex virus type 2 among female sex workers in the Middle East and North Africa: systematic review and meta-analytics.

Authors:  Hiam Chemaitelly; Helen A Weiss; Alex Smolak; Elzahraa Majed; Laith J Abu-Raddad
Journal:  J Glob Health       Date:  2019-12       Impact factor: 4.413

Review 7.  Insects, Rodents, and Pets as Reservoirs, Vectors, and Sentinels of Antimicrobial Resistance.

Authors:  Willis Gwenzi; Nhamo Chaukura; Norah Muisa-Zikali; Charles Teta; Tendai Musvuugwa; Piotr Rzymski; Akebe Luther King Abia
Journal:  Antibiotics (Basel)       Date:  2021-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.